These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 32963028)

  • 1. SARS-CoV-2 organising pneumonia: 'Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?'.
    Kory P; Kanne JP
    BMJ Open Respir Res; 2020 Sep; 7(1):. PubMed ID: 32963028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating hypoxemic patients with SARS-COV-2 pneumonia: Back to applied physiology.
    Bendjelid K; Raphaël G
    Anaesth Crit Care Pain Med; 2020 Jun; 39(3):389-390. PubMed ID: 32305591
    [No Abstract]   [Full Text] [Related]  

  • 3. Happy Hypoxemia in COVID-19-A Neural Hypothesis.
    U R A; Verma K
    ACS Chem Neurosci; 2020 Jul; 11(13):1865-1867. PubMed ID: 32530597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
    Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chest CT imaging features for prediction of treatment response in cryptogenic and connective tissue disease-related organizing pneumonia.
    Cho YH; Chae EJ; Song JW; Do KH; Jang SJ
    Eur Radiol; 2020 May; 30(5):2722-2730. PubMed ID: 32040727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19.
    Fujii H; Tsuji T; Yuba T; Tanaka S; Suga Y; Matsuyama A; Omura A; Shiotsu S; Takumi C; Ono S; Horiguchi M; Hiraoka N
    Clin Rheumatol; 2020 Nov; 39(11):3171-3175. PubMed ID: 32844364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expert recommendations for the diagnosis and treatment of interstitial lung disease caused by novel coronavirus pneumonia].
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Oct; 43(10):827-833. PubMed ID: 32992435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The baby lung and the COVID-19 era.
    Gattinoni L; Meissner K; Marini JJ
    Intensive Care Med; 2020 Jul; 46(7):1438-1440. PubMed ID: 32451579
    [No Abstract]   [Full Text] [Related]  

  • 11. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia.
    Herrmann J; Mori V; Bates JHT; Suki B
    Nat Commun; 2020 Sep; 11(1):4883. PubMed ID: 32985528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailoring steroids in the treatment of COVID-19 pneumonia assisted by CT scans: three case reports.
    Su Y; Han Y; Liu J; Qiu Y; Tan Q; Zhou Z; Yu YZ; Chen J; Giger ML; Lure FYM; Luo Z
    J Xray Sci Technol; 2020; 28(5):885-892. PubMed ID: 32675436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does COVID-19 pneumonia signify secondary organizing pneumonia?: A narrative review comparing the similarities between these two distinct entities.
    Chong WH; Saha BK; Chopra A
    Heart Lung; 2021; 50(5):667-674. PubMed ID: 34098237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.
    Declercq J; Bosteels C; Van Damme K; De Leeuw E; Maes B; Vandecauter A; Vermeersch S; Delporte A; Demeyere B; Vuylsteke M; Lalla M; Smart T; Detalle L; Bouw R; Streffer J; Degeeter T; Vergotte M; Guisez T; Van Braeckel E; Van Der Straeten C; Lambrecht BN
    Trials; 2020 Nov; 21(1):934. PubMed ID: 33213529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pros and cons of corticosteroid therapy for COVID-19 patients.
    Mattos-Silva P; Felix NS; Silva PL; Robba C; Battaglini D; Pelosi P; Rocco PRM; Cruz FF
    Respir Physiol Neurobiol; 2020 Sep; 280():103492. PubMed ID: 32659271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The many faces of interstitial pneumonia: a case of presumed SARS-CoV-2 infection.
    Rigamonti E; Salera D; Gheorghiu AC; Fratila C; Gianella P
    Swiss Med Wkly; 2020 Jun; 150():w20312. PubMed ID: 32662060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen improves lung lesions and hypoxemia in patients with COVID-19.
    Wu Y; Wang T; Guo C; Zhang D; Ge X; Huang Z; Zhou X; Li Y; Peng Q; Li J
    QJM; 2020 Aug; 113(8):539-545. PubMed ID: 32275753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post COVID-19 Organizing Pneumonia: The Right Time to Interfere.
    Bieksiene K; Zaveckiene J; Malakauskas K; Vaguliene N; Zemaitis M; Miliauskas S
    Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33803690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.